Sort
50,496 grants matching “lung cancer”
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
$668,588Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Reducing racial disparities in lung cancer outcomes by decoding neighborhood contextual environment (RECODE)
$668,574Seijeoung Kim · University Of Illinois At Chicago · R01 · FY2021 · MD
Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development
$668,432Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Control of the immune response for cancer vaccine development
$668,432Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Venous Thrombosis in Cancer Outpatients: Prevention and Role of Tissue Factor
$668,427Charles W. Francis · University Of Rochester · R01 · FY2009 · HL
Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas
$668,427Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Special Mouse Strains Resource
$668,317Leah Rae B Donahue · Jackson Laboratory · P40 · FY2008 · RR
Minimally invasive microwave antennas for image-guided focal tumor ablation
$668,234Richard William Schefelker · Neuwave Medical, Inc. · R44 · FY2009 · CA
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
$668,222Jane Amanda Skok · New York University School Of Medicine · R01 · FY2024 · CA
Improving Cancer Outcomes for African-Americans
$668,211New Hanover Regional Medical Center · U56 · FY2005 · CA
Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy
$668,129Richard Leo Wahl · Johns Hopkins University · U01 · FY2012 · CA
Common Pathogenetic Mechanisms of Lung Cancer and COPD
$668,065Chris H Wendt · University Of Minnesota · R01 · FY2013 · HL
Secondary Prevention through Surveillance and Intervention
$668,058Lewis A Chodosh · University Of Pennsylvania · R01 · FY2017 · CA
Gene-tobacco carcinogen interactions and lung cancer risk - a novel approach for precision cancer prevention
$668,019Philip Lazarus · Washington State University · R01 · FY2023 · CA
Outcomes in Rheumatic Diseases
$667,988Michael Ward · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
$667,974Fred Hutchinson Cancer Research Center · U01 · FY2004 · CA
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
$667,924Julie A Sterling · Vanderbilt University Medical Center · R01 · FY2023 · CA
Project 4: The role of codon bias in RAS tumorigenesis
$667,732Christopher M Counter · Univ Of North Carolina Chapel Hill · P01 · FY2020 · CA
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
$667,641Hugo Aerts · Dana-Farber Cancer Inst · U01 · FY2017 · CA
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
$667,641Hugo Aerts · Dana-Farber Cancer Inst · U01 · FY2016 · CA
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
$667,612Hugo Aerts · Dana-Farber Cancer Inst · U01 · FY2015 · CA
Research Program
$667,602Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2021 · CA
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
$667,601Yaqing Zhang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Translating buccal nanocytology for lung cancer screening into clinical practice
$667,591Vadim Backman · Northwestern University · R01 · FY2025 · CA
Targeting Lymphoma: A Multimodal Approach using Radiation, CART-19 Therapy, and Gut Microbiome Modulation
$667,533Andrea Facciabene · University Of Pennsylvania · R01 · FY2025 · CA